Breaking India News Today | In-Depth Reports & Analysis – IndiaNewsWeekBreaking India News Today | In-Depth Reports & Analysis – IndiaNewsWeek
  • Home
  • Nation
  • Politics
  • Economy
  • Sports
  • Entertainment
  • International
  • Technology
  • Auto News
Reading: Blue Jet Healthcare: An Attractive Buy Opportunity
Share
Breaking India News Today | In-Depth Reports & Analysis – IndiaNewsWeekBreaking India News Today | In-Depth Reports & Analysis – IndiaNewsWeek
  • Home
  • Nation
  • Politics
  • Economy
  • Sports
  • Entertainment
  • International
  • Technology
  • Auto News
© 2024 All Rights Reserved | Powered by India News Week
Trending Now: Stay updated with the latest breaking news from India and around the world
Broker’s call: Blue Jet Healthcare (Buy)
Breaking India News Today | In-Depth Reports & Analysis – IndiaNewsWeek > Economy > Blue Jet Healthcare: An Attractive Buy Opportunity
Economy

Blue Jet Healthcare: An Attractive Buy Opportunity

Economy Desk By Economy Desk March 22, 2025 1 Min Read
Share
SHARE

Blue Jet Healthcare is being initiated with a BUY rating and a target price of ₹1,150. The company’s simplified business model, which includes being a standalone entity with a lean cost structure and a debt-free balance sheet, as well as a niche portfolio, positions it for strong margins and returns. Blue Jet is expected to benefit from the global sales of Bempedoic Acid, which are projected to surpass $1 billion by CY27E.

There are potential upside risks to the estimated 31% CAGR in Bempedoic Acid intermediate sales, especially with the expected commercialization of the product in multiple geographies and the introduction of triple combination products. Furthermore, the company’s scale-up in CDMO, along with a projected 20% CAGR in core contrast media intermediate and high-intensity sweetener sales, is expected to drive EBITDA and PAT growth over FY25-27.

Blue Jet’s strong financial metrics, including over 35% EBITDA margin, 25% RoE, and 35% RoCE – the highest in the CDMO peer-set, support its near-term earnings visibility. These factors are reflected in the target multiples. Overall, Blue Jet Healthcare is well-positioned for growth and offers investors a compelling opportunity.

TAGGED:Economy NewsNews
Share This Article
Twitter Copy Link
Previous Article Hungryroot Meal Kit Review (2025): AI-Guided Menu Hungryroot Meal Kit Review (2025): Discover AI-Curated Deliciousness for Every Plate
Next Article Markets soar as FII inflows drive broad-based rally; Sensex breaches 77K intraday  FII Inflows Propel Sensex to Record Intraday High
Leave a comment Leave a comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Latest News

Stock Market Today Live, Nov 16: Sensex, Nifty pare early gains as investors assess sustainability of market rally

Market Update: Sensex and Nifty Trim Early Gains Amid Investor Concerns on Rally Longevity

November 16, 2026
Mahindra's electric three-wheeler arm eyes IPO in 18 months

Mahindra’s Electric Three-Wheeler Division Plans IPO Within 18 Months Amid Growing Demand

November 16, 2026
Photos: Pope Leo visits Peru’s Amazon and Andean regions during 12-day tour

Pope Leo Embarks on 12-Day Tour of Peru’s Amazon and Andean Regions

November 16, 2026
SEBI bars EKI Energy MD Manish Dabkara for 12 months over financial misrepresentation

SEBI Suspends EKI Energy’s Manish Dabkara for 12 Months Due to Financial Misrepresentation

November 1, 2026
A cure for Trump? Why Democratic doctors are running in the 2026 midterms

Democratic Doctors Aim to Counter Trump Influence in 2026 Midterms

November 1, 2026
Tech Query: ICICI Prudential Asset Management Company (AMC), Latent View Analytics, Rashtriya Chemicals and Fertilizers, IRB Infrastructure Developers — What is the outlook? Where are these stocks headed? 

Market Outlook: Future Prospects for Sundram Fasteners, HDB Financial, Sterlite Tech, and Techno Electric

October 31, 2026

You Might Also Like

Sagility India shares hit upper circuit on strong Q3 performance 
Economy

Sagility India soars on robust Q3 results, hits upper circuit

2 Min Read
Gold hits $3,000 an ounce for first time amid trade tensions, Fed rate cut bets
Economy

Gold reaches $3,000/ounce as trade tensions and Fed rate cut predictions rise.

2 Min Read
Broker’s Call: Mastek (Buy) - The HinduBusinessLine
Economy

Mastek Stock Rated ‘Buy’ by Brokers: Insights from The Hindu BusinessLine

2 Min Read
L&T Energy Green Tech partners with John Cockerill on renewable energy technologies 
Economy

L&T Energy Green Tech collaborates with John Cockerill on renewable energy solutions

1 Min Read

About IndiaNewsWeek

IndiaNewsWeek is your trusted source for breaking news, in-depth analysis, and comprehensive coverage of India and the world. We deliver accurate, timely reporting across politics, economy, sports, entertainment, and technology.

contact@indianewsweek.com

Quick Links

  • Nation
  • Politics
  • Economy
  • International
  • Sports
  • Entertainment

More Sections

  • Technology
  • Auto News
  • Education
  • About Us
  • Contact
  • Privacy Policy

Stay Connected

Follow us on social media for the latest updates and breaking news.

Facebook
X (Twitter)
YouTube
Follow US
© 2026 IndiaNewsWeek. All Rights Reserved.
Welcome Back!

Sign in to your account

Lost your password?